1. Show article details.

    Looking Into Vapotherm's Return On Capital Employed

    Benzinga – 9:52 AM ET 05/20/2022

    Benzinga Pro data, Vapotherm reported Q1 sales of $21.62 million. Earnings data without context is not clear and can be difficult to base trading decisions on. It is important to keep in mind that ROCE evaluates past performance and is not used as a predictive tool. ROCE is a powerful metric for comparing the effectiveness of capital allocation for similar companies.

  2. Show article details.

    90 Biggest Movers From Yesterday

    Benzinga – 5:44 AM ET 05/13/2022

    90 Biggest Movers From Yesterday

  3. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 12:28 PM ET 05/11/2022

      On Wednesday, 807 companies reached new 52-week lows. The following stocks created new 52-week lows on Wednesday: Be sure to stay with Benzinga for further updates and market-moving news.

  4. Show article details.

    92 Biggest Movers From Friday

    Benzinga – 6:27 AM ET 05/09/2022

  5. Show article details.

    What 4 Analyst Ratings Have To Say About Vapotherm

    Benzinga – 4:33 PM ET 05/06/2022

    Within the last quarter, Vapotherm has observed the following analyst ratings: These 4 analysts have an average price target of $7.5 versus the current price of Vapotherm at $3.645, implying upside. Below is a summary of how these 4 analysts rated Vapotherm over the past 3 months.

  6. Show article details.

    Stocks That Hit 52-Week Lows On Friday

    Benzinga – 12:06 PM ET 05/06/2022

      On Friday, 1043 companies hit new 52-week lows. Stocks dropping to new 52-week lows on Friday: Be sure to monitor Benzinga for the news traders need!

  7. Show article details.

    55 Stocks Moving In Friday's Mid-Day Session

    Benzinga – 12:00 PM ET 05/06/2022

    55 Stocks Moving In Friday's Mid-Day Session

  8. Show article details.

    Benzinga's Top Ratings Upgrades, Downgrades For May 6, 2022

    Benzinga – 10:02 AM ET 05/06/2022

    For Coupang Inc, JP Morgan upgraded the previous rating of Neutral to Overweight. According to Guggenheim, the prior rating for NextGen Healthcare Inc was changed from Neutral to Buy. According to CLSA, the prior rating for Melco Resorts and Entertainment Ltd was changed from Outperform to Buy. Raymond James upgraded the previous rating for Jounce Therapeutics Inc from Outperform to Strong Buy.

  9. Show article details.

    Stocks That Hit 52-Week Lows On Thursday

    Benzinga – 11:38 AM ET 05/05/2022

      During Thursday, 351 stocks hit new 52-week lows. The stocks that set new 52-week lows on Thursday: Be sure to stay with Benzinga for further updates and market-moving news.

  10. Show article details.

    BRIEF-Vapotherm Reports First Quarter 2022 Financial Results

    Reuters – 6:24 PM ET 05/04/2022

    Vapotherm Inc (VAPO): * VAPOTHERM REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS. * Q1 LOSS PER SHARE $0.87. * SEES FY REVENUE $81 MILLION TO $86 MILLION. * Q1 REVENUE FELL 33.1 PERCENT TO $21.6 MILLION. * REINSTATING ANNUAL REVENUE, GROSS MARGIN, AND OPERATING EXPENSE GUIDANCE FOR FISCAL 2022 Source text for Eikon: Further company coverage:

  11. Show article details.

    Recap: Vapotherm Q1 Earnings

    Benzinga – 6:14 PM ET 05/04/2022

    Vapotherm reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:10 PM. Here's what investors need to know about the announcement. Vapotherm missed estimated earnings by 29.69%, reporting an EPS of $-0.83 versus an estimate of $-0.64. Revenue was down $10.69 million from the same period last year.

  12. Show article details.

    Vapotherm Reports First Quarter 2022 Financial Results

    Business Wire – 4:10 PM ET 05/04/2022

    Revenue of $21.6 Million In-Line with Preliminary Revenue of $20.5 Million to $21.5 Million Vapotherm, Inc. (VAPO), today announced first quarter 2022 financial results. First Quarter 2022 Summary “The first quarter of 2022 was challenging as respiratory patient census was low for both seasonal respiratory illnesses such as flu and RSV and for patients suffering from COPD and CHF.

  13. Show article details.

    Earnings Scheduled For May 4, 2022

    Benzinga – 4:36 AM ET 05/04/2022

      ** Seres Therapeutics is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million. ** Obsidian Energy is projected to report quarterly earnings at $0.41 per share on revenue of $156.00 million. ** International Seaways is estimated to report quarterly loss at $0.31 per share on revenue of $96.75 million.

  14. Show article details.

    Vapotherm to Report First Quarter 2022 Financial Results

    Business Wire – 8:30 AM ET 05/02/2022

    Vapotherm, Inc. (VAPO), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm (VAPO) high velocity therapy® products which are used to treat patients of all ages suffering from respiratory distress, today announced that it will release financial results for the first quarter of 2022 after the close of trading on Wednesday, May 4, 2022.

  15. Show article details.

    Stocks That Hit 52-Week Lows On Thursday

    Benzinga – 3:31 PM ET 04/28/2022

      During Thursday, 849 stocks hit new 52-week lows. During the morning session of trading on Thursday, the following stocks broke to new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  16. Show article details.

    Stocks That Hit 52-Week Lows On Wednesday

    Benzinga – 2:41 PM ET 04/27/2022

      Wednesday's session saw 784 companies set new 52-week lows. The following stocks set new 52-week lows on Wednesday: Be sure to stay with Benzinga for further updates and market-moving news.

  17. Show article details.

    Stocks That Hit 52-Week Lows On Monday

    Benzinga – 12:01 PM ET 04/25/2022

      On Monday, 721 companies achieved new lows for the year. During Monday, the following stocks set new 52-week lows: Be sure to stay with Benzinga for further updates and market-moving news.

  18. Show article details.

    Stocks That Hit 52-Week Lows On Friday

    Benzinga – 12:26 PM ET 04/22/2022

      On Friday, 431 companies hit new 52-week lows. Here are all the stocks that set new 52-week lows on Friday: Be sure to stay with Benzinga for further updates and market-moving news.

  19. Show article details.

    Stocks That Hit 52-Week Lows On Tuesday

    Benzinga – 11:38 AM ET 04/19/2022

      On Tuesday, 242 companies hit new 52-week lows. The stocks that set new 52-week lows on Tuesday: Be sure to stay with Benzinga for further updates and market-moving news.

  20. Show article details.

    Stocks That Hit 52-Week Lows On Monday

    Benzinga – 11:40 AM ET 04/18/2022

      On Monday, 466 companies hit new 52-week lows. Stocks that set new 52-week lows on Monday are as follows:   Be sure to monitor Benzinga for the news traders need!

Page:

Today's and Upcoming Events

  • Aug
    08

    VAPO to announce Q2 earnings (Unconfirmed)

Past Events (last 90 days)

  • May
    04

    VAPO announced Q1 earnings.

Data provided by Thomson Reuters © 2022

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.